Antioxidant, toxic and antimicrobial activity of Rosmarinus officinalis, Ruta graveolens and Juglans regia against Helicobacter pylori

Helicobacter pylori is a Gram negative bacteria with ahigh prevalence worldwide, causing gastric and duodenal ulcers and cancer,  it is one of the main public health problems in Mexico. This work evaluates the in vitro antioxidant, toxic, antibacterial activity, and the ability to inhibit the biofil...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Perales Flores, LCA. Juanita Deniss, Verde-Star, Dra. Maria Julia, Viveros Valdéz, Dr. José Ezequiel, Barrón-González, Dra. María Porfiria, Garza-Padrón, Dra. Ruth Amelia, Aguirre Arzola, Dr. Víctor Eustorgio, Rodriguez Garza, Dr. Ramón Gerardo
Format: Online
Langue:spa
Publié: Universidad de Sonora 2022
Accès en ligne:https://biotecnia.unison.mx/index.php/biotecnia/article/view/1773
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Helicobacter pylori is a Gram negative bacteria with ahigh prevalence worldwide, causing gastric and duodenal ulcers and cancer,  it is one of the main public health problems in Mexico. This work evaluates the in vitro antioxidant, toxic, antibacterial activity, and the ability to inhibit the biofilm formed by H. pylori, of the methanolic extract Juglans regia(EMJR) and crude ethanolic extracts of the species Rosmarinus officinalis (EERO) and Ruta graveolens (EERG) collected in the state of Nuevo León, Mexico. Through phytochemical screening, the presence of secondary metabolites was qualitatively determined. The antioxidant capacity by the DPPH method showed that EMJR was the most active with an IC50of 2.759 μg/mL. The EERG and EERO developed inhibition halos of 11 and 16 mm and a MIC of 0.136 and 0.51 mg/ mL respectively, only the EERO inhibits biofilm formation by 83.7%. Toxicity tests on Artemia salina showed weak to moderate toxicity. The results show the potential use of the studied extracts as alternative sources in the search for new treatments against H. pylori.